1st Quarter - Report

TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 21, 2008 $640,000 Replaced
1st Quarter - Amendment Apr 29, 2008 $640,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Customs & Border Protection; Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); State, Dept of (DOS)

Bills named: H.R. 1908 (110th), H.R. 1902 (110th), H.R. 1432 (110th), S. 1145 (110th), S. 316 (110th)

Health Issues HCR

Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
ROBERT FALB New —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; Patent & Trademark Office (PTO); State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Customs & Border Protection; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5839 (110th)

Medicare/Medicaid MMM

S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Patent & Trademark Office (PTO); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); U.S. Customs & Border Protection

Bills named: H.R. 3700 (110th), H.R. 3140 (110th), S. 1951 (110th)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Customs & Border Protection; Federal Trade Commission (FTC); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Federal Trade Commission (FTC); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; U.S. Customs & Border Protection; Patent & Trademark Office (PTO)

Bills named: H.R. 3161 (110th), S. 1859 (110th)

Pharmacy PHA

S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.

LobbyistCovered position, as disclosed
DEBRA BARRETT —
DAVID SANDERS Patent & Trademark Office - Government Affairs

Contacted: Food & Drug Administration (FDA); U.S. Customs & Border Protection; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: S. 623 (110th), S. 438 (110th), S. 1695 (110th), H.R. 1956 (110th), S. 1505 (110th), H.R. 806 (110th), H.R. 5629 (110th), H.R. 1038 (110th), H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.